Big Pharma Worried About RFK’s Agenda
By David Rufful Published 4 mins ago
The pharmaceutical industry is reportedly bracing for potential changes as Robert F. Kennedy Jr. is set to lead Health and Human Services under President-elect Donald Trump. Kennedy has strongly criticized direct-to-consumer drug advertising, a practice allowed only in the U.S. and New Zealand.
Kennedy has vowed to overhaul the FDA, citing alleged ties between the agency and Big Pharma. He wrote, “FDA’s war on public health is about to end. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.”
The FDA, which oversees $3 trillion in products, receives 46% of its budget from pharmaceutical user fees. Critics have argued that such funding is a major conflict of interest.
Kennedy said, “In some categories, their entire departments, like the nutrition department in the FDA, they have to go. They’re not doing their job. They’re not protecting our kids. Why do we have Froot Loops in this country that have 18 or 19 ingredients, and you go to Canada, and it’s got two or three?”
Kennedy’s plans to reform the agency will face legal and logistical hurdles, including federal employee protections and the technical expertise required for regulatory changes.
The pharmaceutical industry is reportedly bracing for potential changes as Robert F. Kennedy Jr. is set to lead Health and Human Services under President-elect Donald Trump. Kennedy has strongly criticized direct-to-consumer drug advertising, a practice allowed only in the U.S. and New Zealand.
Kennedy has vowed to overhaul the FDA, citing alleged ties between the agency and Big Pharma. He wrote, “FDA’s war on public health is about to end. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.”
The FDA, which oversees $3 trillion in products, receives 46% of its budget from pharmaceutical user fees. Critics have argued that such funding is a major conflict of interest.
Kennedy said, “In some categories, their entire departments, like the nutrition department in the FDA, they have to go. They’re not doing their job. They’re not protecting our kids. Why do we have Froot Loops in this country that have 18 or 19 ingredients, and you go to Canada, and it’s got two or three?”
Kennedy’s plans to reform the agency will face legal and logistical hurdles, including federal employee protections and the technical expertise required for regulatory changes.